Flavonoids as prospective compounds for anti-cancer therapy

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 12, 2013, Pages 2821-2831

  Ravishankar, Divyashree ^a   Rajora, Amit Kumar ^a   Greco, Francesca ^a   Osborn, Helen M I ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Anti cancer activity; Flavonoids; Polyphenolics

Indexed keywords

7 HYDROXYFLAVONE; ACACETIN; APIGENIN; BAICALEIN; BAICALIN; CATECHIN; CHRYSIN; DAIDZEIN; DOXORUBICIN; EPIGALLOCATECHIN GALLATE; EUPATORIN; FLAVANONE; FLAVONE; FLAVONOID; FLAVONOL; GALANGIN; GENISTEIN; HESPERETIN; HESPERIDIN; ISOFLAVONE; KAEMPFEROL; LUTEOLIN; MORIN; MYRICETIN; NARINGENIN; PRIMULETIN; QUERCETIN; TANGERETIN; TAXIFOLIN; UNINDEXED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; ENZYME INHIBITION; GLYCOSYLATION; HUMAN; HYDROPHOBICITY; MELANOMA CELL; METHYLATION; MULTIDRUG RESISTANCE; NONHUMAN; OXIDATIVE STRESS; REVIEW;

(TROLOX)-EQUIVALENT ANTIOXIDANT CAPACITY ASSAY; AKT; ANTI-CANCER ACTIVITY; COX; CYCLOOXYGENASE; ERK; EXTRACELLULAR-SIGNAL-REGULATED KINASE; FERRIC REDUCING ABILITY OF PLASMA ASSAY; FLAVONOIDS; FRAP; GLUTATHIONE S-TRANSFERASE; GST; HDM2; HIF-Α; HUMAN DOUBLE MINUTE 2 ONCOGENE; HYPOXIA-INDUCIBLE FACTOR Α; LIPOXYGENASE; LOX; MAMMALIAN TARGET OF RAPAMYCIN; MCL-1; MEMBRANE-TYPE MATRIX METALLOPROTEINASE-14; MT1-MMP; MTOR; MYELOID LEUKEMIA CELL SEQUENCE; NFΚB; NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS; PHOSPHATIDYLINOSITIDE 3-KINASE; PI3K; POLYPHENOLICS; PROTO-ONCOGENE TYROSINE-PROTEIN KINASE; SRC; SYMBOL FOR PROTEIN KINASE B (PKB); TEAC; UDP-GT; URIDINE 5′-DIPHOSPHATE-GALACTOSE;

ANIMALS; FLAVONOIDS; HUMANS; NEOPLASMS;

EID: 84887064917     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.10.004Review     Document Type: Review

References (126)

1. D. Amić, and B. Lučić Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids Bioorg Med Chem 18 2010 28 35
2. D. Amić, D. Davidovič-Amić, D. Bešlo, V. Rastija, B. Lučić, and N. Trinajstić SAR and QSAR of the antioxidant activity of flavonoids Curr Med Chem 14 2007 827 845 (Pubitemid 46477715)
3. B. Annabi, M.P. Lachambre, N. Bousquet-Gagnon, N. Page, D. Gingras, and R. Beliveau Green tea polyphenol (3)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells Biochim Biophys Acta 1542 2002 209 220 (Pubitemid 34165550)
4. C.A. Austin, S. Patel, K. Ono, H. Nakane, and L.M. Fisher Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives Biochem J 282 1992 883 889
5. G. Agullo, L.G. Payrastre, S. Manenti, C. Viala, C. Rémésy, and H. Chap Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition Biochem Pharmacol 53 1997 1649 1657 (Pubitemid 27356094)
6. E. Ansó, A. Zuazo, M. Irigoyen, M.C. Urdaci, A. Rouzaut, and J.J. Martínez-Irujo Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism Biochem Pharmacol 79 2010 1600 1609
7. R. Auerbach, R. Lewis, B. Shinners, L. Kubai, and N. Akhtar Angiogenesis assays: a critical overview Clin Chem 49 2003 32 40 (Pubitemid 36078551)
8. A. Boumendjel, A. Di Pietro, C. Dumontet, and D. Barron Recent advances in the discovery of flavonoids and analogues with high affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance Med Res Rev 22 2002 512 529
9. T. Bansal, M. Jaggi, R.K. Khar, and S. Talegaonkar Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy J Pharm Pharmaceut Sci 12 2009 46 78
10. O.J. Bandele, and N. Osheroff Bioflavonoids as poisons of human topoisomerase II alpha and II beta Biochemistry 46 2007 6097 6108 (Pubitemid 46804906)
11. M.S. Butler Natural products to drugs: natural product-derived compounds in clinical trials Nat Prod Rep 25 2008 475 516 (Pubitemid 351725315)
12. S. Burda, and W. Oleszek Antioxidant and antiradical activities of flavonoids J Agric Food Chem 49 2001 2774 2779 (Pubitemid 32826067)
13. S. Byun, K.W. Lee, S.K. Jung, E.J. Lee, M.K. Hwang, and S.H. Lim Luteolin inhibits protein kinase C (epsilon) and cSrc activities and UVB-induced skin cancer Cancer Res 70 2010 2415 2423
14. A. Bu-Abbas, M.N. Clifford, R. Walker, and C. Ioannides Contribution of caffeine and flavanols in the induction of hepatic phase II activities by green tea Food Chem. Toxicol 36 1998 617 621 (Pubitemid 28369888)
15. W. Bors, W. Heller, C. Michel, and M. Saran Flavonoids as antioxidants: determination of radical-scavenging efficiencies Methods Enzymol 186 1990 343 355 (Pubitemid 20279976)
16. F. Boege, T. Straub, A. Kehr, C. Bosenberg, K. Christiansen, and A. Andersen Selected novel flavones inhibit the DNA binding or the DNA relegation step of eukaryotic topoisomerase J Biol Chem 271 1996 2262 2270 (Pubitemid 26051584)
17. J.A. Beutler, E. Hamel, A.J. Vlietinck, A. Haemers, P. Rajan, and J.N. Roitman Structure-activity requirements for flavone cytotoxicity and binding to tubulin J Med Chem 41 1998 2333 2338 (Pubitemid 28285735)
18. I.F.F. Benzie, and J.J. Strain The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay Anal Biochem 239 1996 70 76
19. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
20. K.D. Croft The chemistry and biological effects of flavonoids andphenolic acids Ann N Y Acad Sci 854 2006 435 442
21. M. Cavia-Saiz, M.D. Busto, M.C. Pilar-Izquierdo, N. Ortega, M. Perez-Mateos, and P. Muñiz Antioxidant properties, radical scavenging activity and biomolecule protection capacity offlavonoidnaringenin and its glycoside naringin: a comparative study J Sci Food Agric 90 2010 1238 1244
22. T.P.T. Cushnie, and A.J. Lamb Recent advances in understanding the antibacterial properties of flavonoids Int J Antimicrob Agents 38 2011 99 107
23. A. Constantinou, R. Mehta, C. Runyan, K. Rao, A. Vaughan, and R. Moon Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships J Nat Prod 58 1995 217 225
24. A.R. Chowdhury, S. Sharma, S. Mandal, A. Goswami, S. Mukhopadhyay, and H.K. Majumder Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I Biochem J 366 2002 653 661 (Pubitemid 35001710)
25. M.R. Cholbi, M. Paya, and M.J. Alcaraz Inhibitory effects of phenolic compounds on CCl4-induced microsomal lipid peroxidation Experientia 47 1991 195 199
26. J.W. Critchfield, C.J. Welsh, J.M. Phang, and G.C. Yeh Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism Biochem Pharmacol 48 1994 1437 1445
27. G. Cao, E. Sofic, and R.L. Prior Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships Free Radic Biol Med 22 1997 749 760 (Pubitemid 27058337)
28. Y. Cao, and R. Cao Angiogenesis inhibited by drinking tea Nature 398 1999 381
29. G. Conseil, H. Baubichon-Cortay, G. Dayan, J.M. Jault, D. Barron, and A. Di Pietro Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein Proc Natl Acad Sci USA 95 1998 9831 9836
30. G. Comte, J.B. Daskiewicz, C. Bayet, G. Conseil, A. Viornery-Vanier, and C. Dumontet C-isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance J Med Chem 44 2001 763 768 (Pubitemid 32171672)
31. G. Cantero, C. Campanella, S. Mateos, and F. Cortés Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin Mutagenesis 5 2006 321 325 (Pubitemid 44546415)
32. K.H. Cho, J.M. Pezzuto, J.L. Bolton, V.E. Steele, G.J. Kelloff, and S.K. Lee Selection of cancer chemopreventive agents based on inhibition of topoisomerase II activity Eur J Cancer 36 2000 2146 2156
33. M. Cushman, D. Nagarathnam, and R.L. Geahlen Synthesis and evaluation of hydroxylated flavones and related compounds as potential inhibitors of the protein-tyrosine kinase p56lck J Nat Prod 54 1991 1345 1352
34. F. Casagrande, and J.M. Darbon Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1 Biochem Pharmacol 61 2001 1205 1215 (Pubitemid 32375112)
35. E. Ciszak, V. Cody, J. Luft, R.J. Kempton, and B.S. Kesler Flavonoid conformational analysis: comparison of the molecular structures of (Z)-4,4′,6-triacetoxyaurone and (Z)-3′,5′-dibromo-2′,4, 4′6-tetrahydroxyaurone monohydrate by crystallographic and molecular orbital methods J Mol Struct 251 1991 345 357
36. P. Carmeliet Angiogenesis in life, disease and medicine Nature. 438 2005 932 936 (Pubitemid 43093958)
37. P. Cos, L. Ying, M. Calomme, J.P. Hu, K. Cimanga, and B. Van Poel Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers J Nat Prod 61 1998 71 76 (Pubitemid 28086977)
38. A.J Dugas Jr., J. Castañeda-Acosta, G.C. Bonin, K.L. Price, N.H. Fischer, and G.W. Winston Evaluation of the total peroxylradicalscavenging capacity of flavonoids: structure-activity relationships J Nat Prod 63 2000 327 331 (Pubitemid 30173687)
39. I. Dolečková, L. Rárová, J. Grúz, M. Vondrusová, M. Strnad, and V. Kryštof Antiproliferative and antiangiogenic effects of flavone eupatorin, an active constituent of chloroform extract of orthosiphonstamineus leaves Fitoterapia 83 2012 1000 1007
40. B. Fu, J. Xue, Z. Li, X. Shi, B.H. Jiang, and J. Fang Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis Mol Cancer Ther 6 2007 220 226 (Pubitemid 46206685)
41. D.R. Ferry, A. Smith, J. Malkhandi, D.W. Fyfe, P.G. de Takats, and D. Anderson Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin Cancer Res 2 1996 659 668 (Pubitemid 26133468)
42. H.G. Farina, M. Pomies, D.F. Alonso, and D.E. Gomez Antitumor and antiangiogenic activity of soy isoflavonegenistein in mouse models of melanoma and breast cancer Oncol Rep 16 2006 885 891
43. J. Fang, Q. Zhou, L.Z. Liu, C. Xia, X. Hu, and X. Shi Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression Carcinogenesis 28 2007 858 864 (Pubitemid 46523341)
44. J. Fang, C. Xia, Z. Cao, J.Z. Zheng, E. Reed, and B.H. Jiang Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways FASEB J 19 2005 342 353 (Pubitemid 40316522)
45. D. Fabbro, S. Ruetz, E. Buchdunger, S.W. Cowan-Jacob, G. Fendrich, and J. Liebetanz Protein kinases as targets for anticancer agents: from inhibitors to useful drugs Pharmacol Ther 93 2002 79 98 (Pubitemid 34615551)
46. M. Ferrali, C. Signorini, B. Caciotti, L. Sugherini, L. Ciccoli, and D. Giachetti Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity FEBS Lett 416 1997 123 129 (Pubitemid 27462770)
47. O. Firuzi, A. Lacanna, R. Petrucci, G. Marrosu, and L. Saso Evaluation of the antioxidant activity of flavonoids by ferric reducing antioxidant power assay and cyclic voltammetry Biochem Biophys Acta 1721 2005 174 184 (Pubitemid 40093525)
48. O. Firuzi, P. Mladenka, R. Petrucci, G. Marrosu, and L. Saso Hypochlorite scavenging activity of flavonoids J Pharm Pharmacol 56 2004 801 807 (Pubitemid 38801696)
49. P.C. Ferriola, V. Cody, and E. Middleton Jr. Protein kinase C inhibition by plant flavonoids: kinetic mechanisms and structure-activity relationships Biochem Pharmacol 38 1989 1617 1624 (Pubitemid 19120080)
50. R.N. Gacche, H.D. Shegokar, D.S. Gond, Z. Yang, and A.D. Jadhav Evaluation of selected flavonoids as antiangiogenic, anticancer, and radical scavenging agents: an experimental and in silico analysis Cell Biochem Biophys 61 2011 651 663
51. L. Gamet-Payrastre, S. Manenti, M.P. Gratacap, J. Tulliez, H. Chap, and B. Payratre Flavonoids and the inhibition of PKC and PI 3-kinase Gen Pharmacol 32 1999 279 286 (Pubitemid 29146039)
52. A. García-Lafuente, E. Guillamón, A. Villares, M.A. Rostagno, and J.A. Martínez Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease Inflamm Res 58 2009 537 552
53. R.L. Geahlen, N.M. Koonchanok, and J.L. Mclaughlin Inhibition of protein-tyrosinase kinase activity by flavonoids and related compounds J Nat Prod 52 1989 982 986 (Pubitemid 19270608)
54. Y. Guo, S. Wang, D.R. Hoot, and S.K. Clinton Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones J Nutr Biochem 18 2007 408 417 (Pubitemid 46727041)
55. N. Gyémánt, M. Tanaka, S. Antus, J. Hohmann, O. Csuka, and L. Mándoky In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells In vivo 19 2005 367 374 (Pubitemid 40467621)
56. B. Halliwell, and J.M.C. Gutteridge Free radicals in biology and medicine 3rd ed. 1998 University Press Oxford
57. G.R. Haenen, J.B. Paquay, R.E. Korthouwer, and A. Bast Peroxynitrite scavenging by flavonoids Biochem Biophys Res Commun 236 1997 591 593 (Pubitemid 27384670)
58. M. Hashemi, N. Behrangi, H. Borna, and M. Entezari Protein tyrosine kinase (PTK) as a novel target for some natural anti-cancer molecules extracted from plants J Med Plants Res 6 2012 64375 64378
59. M. Hadjeri, M. Barbier, X. Ronot, A.M. Mariotte, A. Boumendjel, and J. Boutonnat Modulation of P-glycoprotein-mediatedmultidrug resistance by flavonoid derivativesand analogues J Med Chem 46 2003 2125 2131 (Pubitemid 36583492)
60. K.E. Heim, A.R. Tagliaferro, and D.J. Bobilya Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships J Nutr Biochem 13 2002 572 584 (Pubitemid 35246546)
61. D. Hyde Introduction to genetics principles 1st ed. 2009 McGraw-Hill Education
62. R. Hu, and A.N. Kong Activation of MAP kinases, apoptosis and nutrigenomics of gene expression elicited by dietary cancer-prevention compounds Nutrition 20 2004 83 88 (Pubitemid 38091585)
63. J.P. Hu, M. Calomme, A. Lasure, T. De Bruyne, L. Pieters, and A. Vlietinck Structure-activity relationship of flavonoids with superoxide scavenging activity Biol Trace Elem Res 47 1995 327 331
64. I. Huk, V. Brovkovych, V.J. Nanobash, G. Weigel, C. Neumayer, and L. Partyka Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study Br J Surg 85 1998 1080 1085 (Pubitemid 28360771)
65. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 6 2011 69 90
66. A.M. Joussen, K. Rohrschneider, J. Reichling, B. Kirchhof, and F.E. Kruse Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids Exp Eye Res 71 2000 483 487
67. M. Kiminori, I. Kohji, M. Yoshiyuki, and N. Masaharu Mori Nobuyoshi Anti-angiogenic activity of quercetin and its derivatives Lett Drug Des Discov 1 2004 329 333
68. M. Kawai, T. Hirano, S. Higa, J. Arimitsu, M. Maruta, and Y. Kuwahara Flavonoids and related compounds as anti-allergic substances Allergol Int 56 2007 113 123 (Pubitemid 46984239)
69. S. Kuntz, U. Wenzel, and H. Daniel Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines Eur J Nutr 38 1999 133 142 (Pubitemid 29352529)
70. N. Kerry, and C. Rice-Evans Inhibition of peroxynitrite-mediated oxidation of dopamine by flavonoid and phenolic antioxidants and their structural relationships J Neurochem 73 1999 247 253 (Pubitemid 29289133)
71. S. Lapenna, and A. Giordano Cell cycle kinases as therapeutic targets for cancer Nat Rev Drug Discov 8 2009 547 556
72. B. Lazarevic, G. Boezelijn, L.M. Diep, K. Kvernrod, O. Ogren, and H. Ramberg Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind phase 2 clinical trial Nutr Cancer 63 2011 889 898
73. L.Z. Liu, J. Fang, Q. Zhou, X. Hu, X. Shi, and B.H. Jiang Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer Mol Pharmacol 68 2005 635 643 (Pubitemid 41206017)
74. C.M. Lin, H. Chang, S.Y. Li, I.H. Wu, and J.H. Chiu Chrysin inhibits lipopolysaccharide-induced angiogenesis via down-regulation of VEGF/VEGFR-2(KDR) and IL-6/IL-6R pathways Planta Med 72 2006 708 714 (Pubitemid 44073454)
75. C.M. Lin, H. Chang, Y.H. Chen, I.H. Wu, and J.H. Chiu Wogonin inhibits IL-6-induced angiogenesis via down-regulation of VEGF and VEGFR-1, not VEGFR-2 Planta Med 72 2006 1305 1310 (Pubitemid 44862032)
76. C.M. Lin, H. Chang, Y.H. Chen, S.Y. Li, I.H. Wu, and J.H. Chiu Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1 Int Immunopharmacol 6 2006 1690 1698 (Pubitemid 44344541)
77. C. Lin, M. Wu, and J. Dong Quercetin-4′-O-β-d-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cells PLoS ONE 2012 7
78. T.S. Lin, A.S. Ruppert, A.J. Johnson, B. Fischer, N.A. Heerema, and L.A. Andritsos Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease J Clin Oncol 27 2009 6012 6018
79. H.L. Liu, W.B. Jiang, and M.X. Xie Flavonoids: recent advances as anticancer drugs Recent Pat Anticancer Drug Discov 5 2010 152 164
80. M. López-Lázaro, E. Willmore, and C.A. Austin The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells Mutat Res 696 2010 41 47
81. E. Middleton Jr., C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol Rev 52 2000 673 751
82. J. Mojzisa, L. Varinskaa, G. Mojzisova, I. Kostovac, and L. Mirossaya Anti-angiogenic effects of flavonoids and chalcones Pharmacol Res 57 2008 259 265
83. B. Mishra, K.I. Priyadarsini, M.S. Kumar, M.K. Unnikrishnan, and H. Mohan Effect of O-glycosilation on the antioxidant activity and free radical reactions of a plant flavonoid, chrysoeriol Bioorg Med Chem 11 2003 2677 2685 (Pubitemid 36682991)
84. A.K. Mc Clendon, and N. Osheroff DNA topoisomerase II, genotoxicity, and cancer Mutat Res 623 2007 83 97 (Pubitemid 47368578)
85. M-.H. Pan, W-.J. Chen, S-.Y. Lin-Shiau, C-.T. Ho, and J-.K. Lin Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells Carcinogenesis 23 2002 1677 1684
86. R.J. Nijveldt, E. van Nood, D.E.C. van Hoorn, P.G. Boelens, K. van Norren, and P.A.M. van Leeuwen Flavonoids: a review of probable mechanisms of action and potential applications Am J Clin Nutr 74 2001 418 425 (Pubitemid 32880250)
87. D.E. Nerland The antioxidant/electrophile response element motif Drug Metab Rev 39 2007 235 248
88. K. Padget, R. Carr, A.D. Pearson, M.J. Tilby, and C.A. Austin Camptothecin-stabilised topoisomerase I-DNA complexes in leukemia cells visualised and quantified in situ by the TARDIS assay (trapped in agarose DNA immunostaining) Biochem Pharmacol 59 2000 629 638 (Pubitemid 30085444)
89. M. Piao, D. Mori, T. Satoh, Y. Sugita, and O. Tokunaga Inhibition of endothelial cell proliferation, in vitro angiogenesis, and the down-regulation of cell adhesion-related genes by genistein. Combined with a cDNA microarray analysis Endothelium 13 2006 249 266 (Pubitemid 44463534)
90. J. Pines Cyclins and cyclin-dependent kinasesa biochemical view Biochem J 308 1995 697 711
91. A. Pietro, Di, G. Conseil, J.M. Pérez-Victoria, G. Dayan, and H. Baubichon-Cortay Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters Cell Mol Life Sci 59 2002 307 322 (Pubitemid 34169516)
92. P.G. Pietta Flavonoids as antioxidants J Nat Prod. 63 2000 1035 1042
93. P. Pratheeshkumar, A. Budhraja, Y.-O. Son, X. Wang, Z. Zhang, and S. Ding Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR-2 regulated AKT/mTOR/P70S6K signaling pathways PLoS ONE 7 2012 10
94. P. Pratheeshkumar, Y.-O. Son, A. Budhraja, X. Wang, S. Ding, and Wang Lei Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis PLoS ONE 7 2012 12
95. D. Procházková, I. Boušová, and N. Wilhelmová Antioxidant and prooxidant properties of flavonoids Fitoterapia 82 2011 513 523
96. K.H. Plate, G. Breier, H.A. Weich, and W. Risau Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo Nature 359 1992 845 848
97. A.K. Ratty, and N.P. Das Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship Biochem Med Metab Biol 39 1988 69 79 (Pubitemid 18067508)
98. C.A. Rice-Evans, N.J. Miller, and G. Paganga Structure-antioxidant activity relationships of flavonoids and phenolic acids Radic Biol Med 20 1996 933 956 (Pubitemid 26157509)
99. C. Rice-Evans, and N.J. Miller Total antioxidant status in plasma and body fluids Methods Enzymol 234 1994 279 293
100. W. Ren, Z. Qiao, H. Wang, L. Zhu, and L. Zhang Flavonoids: promising anticancer agents Med Res Rev 23 2003 519 534 (Pubitemid 36706514)
101. H. Rubbo, R. Radi, M. Trujillo, R. Telleri, B. Kalyanaraman, and S. Barnes Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation J Biol Chem 269 1994 26066 26075
102. G. Scambia, F.O. Ranelletti, P.B. Panici, R. De Vincenzo, G. Bonanno, and G. Ferrandina Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target Cancer Chemother Pharmacol 34 1994 459 464 (Pubitemid 24306043)
103. A. Sekher Pannala, T.S. Chan, P.J. O'Brien, and C.A. Rice-Evans Flavonoid B-ring chemistry and antioxidant activity: fast reaction kinetics Biochem Biophys Res Commun 282 2001 1161 1168 (Pubitemid 32912847)
104. A.B. Shapiro, and V. Ling Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein Biochem Pharmacol 53 1997 587 596 (Pubitemid 27149553)
105. G.I. Shapiro Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol Clin Cancer Res 10 2004 4270 4275
106. F.J. Sharom ABC multidrug transporters: structure, function and role in chemoresistance Pharmacogenomics 9 2008 105 127 (Pubitemid 351560534)
107. I. Shchemelinin, L. Šefc, and E. Necas Protein kinases, their functions and implication in cancer and other diseases Folia Biol 52 2006 81 101 (Pubitemid 44262744)
108. R.P. Singh, and R. Agarwal Natural flavonoids targeting deregulated cell cycle progression in cancer cells Curr Drug Targets 7 2006 345 354 (Pubitemid 43744850)
109. S.J. Su, T.M. Yeh, W.J. Chuang, C.L. Ho, K.L. Chang, and H.L. Cheng The novel targets for anti-angiogenesis of genistein on human cancer cells Biochem Pharmacol 69 2005 307 318
110. C. Sun, J. Fu, J. Chen, L. Jiang, and Y. Pan On-line HPLC method for screening of antioxidants against superoxide anion radical from complex mixtures J Sep Sci 33 2010 1018 1023
111. B. Sung, M.K. Pandey, and B.B. Aggarwal Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation Mol Pharmacol 71 2007 1703 1714 (Pubitemid 47010923)
112. T. Strachan, and A.P. Read Human molecular genetics 2nd ed. 1999 Wiley-Liss New York
113. Z. Topcu, B. Ozturk, O. Kucukoglu, and E. Kilinc Flavonoids in helichrysumpamphylicum inhibit mammalian type I DNA topoisomerase Zeitschriftfür Naturforschung C 63 2008 69 74 (Pubitemid 351363399)
114. D. Taubert, T. Breitenbach, A. Lazar, P. Censarek, S. Harlfinger, and R. Berkels Reaction rate constants of superoxide scavenging by plant antioxidants Free Radic Biol Med 35 2003 1599 1607 (Pubitemid 37532911)
115. I.B. Tsyrlov, V.M. Mikhailenko, and H.V. Gelboin Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P450s to different flavonoids Biochim Biophys Acta 205 1994 325 335 (Pubitemid 24115026)
116. S.A.B.E. Van Acker, M.J.D. Groot, D.J. Van den Berg, M.N.J.L. Tromp, G.D.O. Den Kelder, and W.J.F. Van der Vijgh A quantum chemical explanation of the antioxidant activity of flavonoid Chem Res Toxicol 9 1996 1305 1312 (Pubitemid 26403836)
117. C.H.M. Versantvoort, G.J. Schuurhuis, H.M. Pinedo, C.A. Eekman, C.M. Kuiper, and J. Lankelma Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells Br J Cancer 68 1993 939 946 (Pubitemid 23315227)
118. T. Yamasaki, A. Takahashi, J. Pan, N. Yamaguchi, and K.K. Yokoyama Phosphorylation of activation transcription factor-2 at serine 121 by protein kinase C controls c-Jun-mediated activation of transcription J Biol Chem 284 2009 8567 8581
119. X. Yu, J. Zhu, M. Mi, W. Chen, and Q. Pan Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation Med Oncol 29 2012 349 357
120. L.M. Wang, and D.M. Ren Flavopiridol, the first cyclin-dependent kinase inhibitor: recent advances in combination chemotherapy Mini Rev Med Chem 10 2010 1058 1070
121. E.F. Wagner, and A.R. Nebreda Signal integration by JNK and p38 MAPK pathways in cancer development Nat Rev Cancer 9 2009 537 549
122. M.R. Webb, and S.E. Ebeler Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity Biochem J 384 2004 527 541 (Pubitemid 40018966)
123. E. Willmore, A.J. Frank, K. Padget, M.J. Tilby, and C.A. Austin Etoposide targets topoisomerase II alpha and II beta in leukemic cells: isoform-specific cleavable complexes visualized and quantified in situ by a novel immunofluorescence technique Mol Pharmacol 54 1998 78 85 (Pubitemid 28337589)
124. M. Zhu, and W.E. Fahl Functional characterization of transcription regulators that interact with the electrophile response element Biochem Biophys Res Commun 23 2001 212 219 (Pubitemid 33108816)
125. B. Zhang, L. Liu, S. Zhao, X. Wang, L. Liu, and S. Li Vitexicarpin acts as a novel angiogenesis inhibitor and its target network Evid Based Complement Alternat Med 2013 2013 278405
126. S. Zhang, and M.E. Morris Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport J Pharmacol Exp Ther 304 2003 1258 1267 (Pubitemid 36254439)